Control Bionics Limited Price (CBL.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

159,393,290

(59.3121)%

Control Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a device to control a range of devices, including wheelchairs, dining robots, and g... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.037-0.105
  • Market Cap 10.90M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Mr. Jeremy E. Steele
  • IPO Date: December, 06, 2020
  • Country: AU
  • Currency: AUD
  • Headquaters: Camberwell, VIC
  • Employees: 25

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation